journal article·2024-09Open access

Gasdermin D Mediated Mitochondrial Metabolism Orchestrate Neurogenesis Through LDHA During Embryonic Development

Hongyan Ma, Huiyang Jia, Wenzheng Zou, Fen Ji, Wenwen Wang, Jinyue Zhao, Chenqi Yuan, Jianwei Jiao

Advanced Science· Volume 11· Issue 35

Abstract

Abstract Regulatory cell death is an important way to eliminate the DNA damage that accompanies the rapid proliferation of neural stem cells during cortical development, including pyroptosis, apoptosis, and so on. Here, the study reports that the absence of GSDMD‐mediated pyroptosis results in defective DNA damage sensor pathways accompanied by aberrant neurogenesis and autism‐like behaviors in adult mice. Furthermore, GSDMD is involved in organizing the mitochondrial electron transport chain by regulating the AMPK/PGC‐1α pathway to target Aifm3. This process promotes a switch from oxidative phosphorylation to glycolysis. The perturbation of metabolic homeostasis in neural progenitor cells increases lactate production which acts as a signaling molecule to regulate the p38MAPK pathway. And activates NF‐𝜿B transcription to disrupt cortex development. This abnormal proliferation of neural progenitor cells can be rescued by inhibiting glycolysis and lactate production. Taken together, the study proposes a metabolic axis regulated by GSDMD that links pyroptosis with metabolic reprogramming. It provides a flexible perspective for the treatment of neurological disorders caused by genotoxic stress and neurodevelopmental disorders such as autism.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Inflammasome and immune disorders · Genetics and Neurodevelopmental Disorders · Autophagy in Disease and Therapy

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Organ Regeneration and Reconstruction, State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology Chinese Academy of Science Beijing 100101 China

University of Chinese Academy of Sciences Beijing 100049 China

Beijing Institute for Stem Cell and Regenerative Medicine Institute for Stem Cell and Regeneration Chinese Academy of Sciences Beijing 100101 China

Co‐Innovation Center of Neuroregeneration Nantong University Nantong 226001 China

Funding

National Natural Science Foundation of China · National Key Research and Development Program of China

References (70)

Show source-provided references
1. 10.1038/nrn200810.1038/nrn2008 ↗
2. 10.1016/j.neuron.2013.06.01710.1016/j.neuron.2013.06.017 ↗
3. 10.1038/nn117210.1038/nn1172 ↗
4. 10.1016/0092-8674(95)90035-710.1016/0092-8674(95)90035-7 ↗
5. 10.1016/j.tig.2014.04.00110.1016/j.tig.2014.04.001 ↗
6. Durak O. · Nat. Neurosci. · 2016
7. 10.1038/nature0772510.1038/nature07725 ↗
8. 10.1016/0022-1910(65)90099-510.1016/0022-1910(65)90099-5 ↗
9. 10.1038/nature1551410.1038/nature15514 ↗
10. 10.1016/j.tcb.2017.05.00510.1016/j.tcb.2017.05.005 ↗
11. 10.1073/pnas.141909011210.1073/pnas.1419090112 ↗
12. 10.1038/nature0771010.1038/nature07710 ↗
13. Poh L. · Exp. Neurol. · 2021 · 346
14. 10.1038/s41586-020-2174-310.1038/s41586-020-2174-3 ↗
15. Ma C. · Sci. Adv. · 2020 · 6
16. Karmakar M. · Nat. Commun. · 2020 · 11
17. Zheng G. · J. Res. Med. Ences. · 2015 · 20 · 185
18. 10.1038/nature1551410.1038/nature15514 ↗
19. Li Z. · Nature. · 2021 · 599 · 1
20. 10.1016/j.ijdevneu.2014.08.00210.1016/j.ijdevneu.2014.08.002 ↗
21. 10.1016/0896-6273(95)90067-510.1016/0896-6273(95)90067-5 ↗
22. 10.1016/j.stem.2016.04.01510.1016/j.stem.2016.04.015 ↗
23. 10.1016/j.cell.2013.03.02710.1016/j.cell.2013.03.027 ↗
24. 10.1016/j.bmc.2021.11652210.1016/j.bmc.2021.116522 ↗
25. 10.1038/ng118010.1038/ng1180 ↗
26. 10.1016/j.scitotenv.2022.15672710.1016/j.scitotenv.2022.156727 ↗
27. Yang X. · Immunity. · 2019 · 51
28. Racioppi L. · Nat. Commun. · 2019 · 10
29. 10.1016/j.molcel.2015.04.02010.1016/j.molcel.2015.04.020 ↗
30. 10.1038/cdd.2010.9210.1038/cdd.2010.92 ↗
31. 10.1042/BST036097610.1042/BST0360976 ↗
32. Kowaltowski A. J. · Off. J. Oxygen Soc. · 2009 · 47
33. Zhao R. Z. · Int. J. Mol. Med. · 2019 · 44 · 3
34. 10.1038/nrm227510.1038/nrm2275 ↗
35. 10.1016/j.cell.2022.06.03810.1016/j.cell.2022.06.038 ↗
36. 10.1016/j.stem.2016.04.01510.1016/j.stem.2016.04.015 ↗
37. 10.1016/j.devcel.2020.09.02810.1016/j.devcel.2020.09.028 ↗
38. 10.1016/j.cmet.2018.01.01110.1016/j.cmet.2018.01.011 ↗
39. Lin X. · Oncogenesis. · 2020 · 9
40. 10.1016/j.bbrc.2021.04.08210.1016/j.bbrc.2021.04.082 ↗
41. 10.1073/pnas.080824910510.1073/pnas.0808249105 ↗
42. 10.1038/s41593-022-01093-710.1038/s41593-022-01093-7 ↗
43. 10.1126/science.aba976010.1126/science.aba9760 ↗
44. 10.1126/science.116080910.1126/science.1160809 ↗
45. Pająk B. · Int. J. Mol. Sci. · 2019 · 21
46. 10.1038/nrn.2018.1910.1038/nrn.2018.19 ↗
47. 10.1038/s41380-021-01122-010.1038/s41380-021-01122-0 ↗
48. 10.1038/s42255-022-00708-410.1038/s42255-022-00708-4 ↗
49. 10.1038/s42255-022-00709-310.1038/s42255-022-00709-3 ↗
50. Miermont A. · Development. · 2019 · 146
51. 10.1016/j.immuni.2017.11.01310.1016/j.immuni.2017.11.013 ↗
52. Zheng A. · BMC Cancer. · 2019 · 19
53. 10.1038/nrneurol.2014.22810.1038/nrneurol.2014.228 ↗
54. 10.1126/science.109932010.1126/science.1099320 ↗
55. 10.1038/ncb190710.1038/ncb1907 ↗
56. 10.1590/1516-4446-2013-S10410.1590/1516-4446-2013-S104 ↗
57. 10.1515/revneuro-2014-005610.1515/revneuro-2014-0056 ↗
58. 10.1038/mp.2010.13610.1038/mp.2010.136 ↗
59. 10.1002/aur.302910.1002/aur.3029 ↗
60. 10.1016/j.cell.2020.08.04910.1016/j.cell.2020.08.049 ↗
61. Cheng N. · Front. Mol. Neurosci. · 2017 · 10
62. Pan C. · Front. Neurosci. · 2019 · 13
63. 10.1101/pdb.prot09401110.1101/pdb.prot094011 ↗
64. 10.1038/nbt.187710.1038/nbt.1877 ↗
65. 10.1016/j.cyto.2018.08.00810.1016/j.cyto.2018.08.008 ↗
66. 10.1038/nprot.2006.27610.1038/nprot.2006.276 ↗
67. 10.1111/j.1600-079X.2009.00741.x10.1111/j.1600-079X.2009.00741.x ↗
68. 10.1016/j.celrep.2018.11.04410.1016/j.celrep.2018.11.044 ↗
69. 10.1038/nn.464810.1038/nn.4648 ↗
70. Esteban S. · J. Pineal Res. · 2010 · 48